The Daily Fuckup

The White House’s April 2 tariff announcements came in two parts: one aimed at patented pharmaceutical products and ingredients, and another that tightened the metal duties on steel, aluminum and copper. The drugs order sets a 100% tariff on covered patented pharmaceutical products and ingredients, but the White House says that rate is not universal. The order and fact sheet describe exceptions for certain onshoring commitments, country-specific treatment tied to trade and security frameworks, and zero-rate categories that include orphan drugs, nuclear medicines, plasma-derived therapies, fertility treatments, cell and gene therapies, antibody-drug conjugates, medical countermeasures and some animal-health products. ([whitehouse.gov](https://www.whitehouse.gov/fact-sheets/2026/04/fact-sheet-president-donald-j-trump-bolsters-national-security-and-strengthens-u-s-supply-chains-by-imposing-tariffs-on-patented-pharmaceutical-products/?utm_source=openai))

The metals action has a different clock. The proclamation says the added duties apply to goods entered for consumption or withdrawn from warehouse for consumption on or after 12:01 a.m. Eastern Daylight Time on April 6, 2026, with separate treatment for certain copper articles and aluminum and steel derivative articles. It also says the duties are assessed on the full customs value of the imported product, not just the metal content, and that the rate structure differs depending on the product category. ([whitehouse.gov](https://www.whitehouse.gov/fact-sheets/2026/04/fact-sheet-president-donald-j-trump-strengthens-tariffs-on-steel-aluminum-and-copper-imports/?utm_source=openai))

That distinction matters because the White House is not describing one flat tariff pile. It is creating a set of rules with different effective dates, different product definitions and different carve-outs. For importers, that means classification, country of origin, entry date and product composition all matter. For manufacturers, it means a shipment can be covered, exempted or taxed at a different rate depending on how it is described, where it came from and whether the buyer or supplier has qualified for a separate treatment under the order. ([whitehouse.gov](https://www.whitehouse.gov/fact-sheets/2026/04/fact-sheet-president-donald-j-trump-bolsters-national-security-and-strengthens-u-s-supply-chains-by-imposing-tariffs-on-patented-pharmaceutical-products/?utm_source=openai))

The politics are straightforward. The mechanics are not. The administration wants tariffs that look aggressive enough to reshape sourcing and reward domestic production. But the actual effect depends on customs enforcement, paperwork, supply contracts and the timing built into the orders themselves. The more the policy relies on exceptions, phase-ins and product-specific rules, the less it behaves like a single strike and the more it looks like an administrative maze with a tax attached. ([whitehouse.gov](https://www.whitehouse.gov/fact-sheets/2026/04/fact-sheet-president-donald-j-trump-bolsters-national-security-and-strengthens-u-s-supply-chains-by-imposing-tariffs-on-patented-pharmaceutical-products/?utm_source=openai))